ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Kal Minerals Corp

Kal Minerals Corp (KAL)

0.14
0.00
(0.00%)
Closed 26 January 8:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.14
Bid
0.135
Offer
0.40
Volume
-
0.00 Day's Range 0.00
0.14 52 Week Range 0.14
Previous Close
0.14
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

KAL Latest News

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, May 24 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drugs for the treatment of cancer and inflammatory diseases, announced today...

Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal

History of Atiprimod Appears in Genetic Engineering & Biotechnology News NEW YORK, May 15 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.140.140.1400CS
4000.140.140.1400CS
12000.140.140.1400CS
26000.140.140.1400CS
52000.140.140.1400CS
156000.140.140.1400CS
2600.06750.080.160.0816010.12165007CS

KAL - Frequently Asked Questions (FAQ)

What is the current Kal Minerals share price?
The current share price of Kal Minerals is $ 0.14
What is the 1 year trading range for Kal Minerals share price?
Kal Minerals has traded in the range of $ 0.14 to $ 0.14 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLKMMayo Lake Minerals Inc
$ 0.035
(133.33%)
13k
CATCAT Strategic Metals Corporation
$ 0.01
(100.00%)
2k
BHCCBlue Horizon Global Capital Corp
$ 0.01
(100.00%)
4k
IANiAnthus Capital Holdings Inc
$ 0.01
(100.00%)
85k
AWRAurwest Resources Corporation
$ 0.01
(100.00%)
3k
DDDouble Deuce Exploration Corp
$ 0.11
(-54.17%)
1.05k
AFXArctic Fox Lithium Corp
$ 0.005
(-50.00%)
38.33k
PNGCLoyalist Exploration Limited
$ 0.005
(-50.00%)
300k
TUGATuga Innovations Inc
$ 0.01
(-50.00%)
62k
SURESureNano Science Ltd
$ 0.08
(-44.83%)
34.5k
NFLDExploits Discovery Corp
$ 0.04
(0.00%)
3.51M
ONCOOnco Innovations Limited
$ 2.55
(15.91%)
3.05M
WHIPCredissential Inc
$ 0.105
(-19.23%)
2.73M
HVWHi View Resources Inc
$ 0.055
(-15.38%)
1.96M
BCBCBC Bud Corporation
$ 0.14
(0.00%)
1.53M

Discussion

View Full Feed
wxdog wxdog 2 minutes ago
Wow, every day you are here posting foolishness about nothing pertinent to Xcelerate’s current situation? IMO

I haven’t really a clue why? You sure don’t seem very educated, but impressions are just that I guess. Your BIO nails it pretty much. Just say’n.

You don’t care
XCRT
MartinLutherKing MartinLutherKing 3 minutes ago
Transcode Therapeutics FDA fast track approval coming…..

Lead candidate: TTX-MC138 – phase 1/2
Area of focus: Cancer
Recent news: FDA clearance to initiate phase 1/2
TransCode Therapeutics is a clinical-stage oncology company based in Boston, Massachusetts, focus
RNAZ
BirdsOfFire BirdsOfFire 3 minutes ago
Justafax, I will not call just yet. But the name change is happening. IMO. If the name change was not happening, then why does Schwab now have the new name for KGKG as NUVIBE, Inc. This change is recent.

I refuse to get bothered about something I have no control over. I too hav
KGKG
2H2 2H2 4 minutes ago
Deepsake. Goodbye big tech.
SPY
Good Sport Good Sport 4 minutes ago
Loc, any guess as to when that 11,105,808 B patent would expire? I didn't quite understand the prior patents that made up this and then the * mark stating it was subject to early termination. It also has a little over a year of additional extention to it from uspto.


RELATED AP
HDVY
AlwaysRed AlwaysRed 5 minutes ago
It's nice to see people actually thinking and not just parroting metal salesmen:

https://www.zerohedge.com/markets/do-money-supply-deficits-qe-create-inflation

"While Michael argued during the debate that increased “money printing” would lead to higher inflation and int
SLV
Mufaso Mufaso 5 minutes ago
I agree investing in "all things manufacturing" related to GLP1's make sense and in this case the injectable forms.

Becton Dickinson is a very well respected name and has been a leaded in making pre filled syringes for a very long time. As a point of clarification for anyone who is i
BDX LLY NVO
Testpilot Testpilot 6 minutes ago
Two different series D Shares buys on Dec 17th and Jan 9th for about 14 million total. Something good is happening. Expert Market was anticipated as Coretec said filing would be late . I've been anticipating this for some time and have been waiting for it ..next step the filing comes out, and at som
CRTG
omda omda 6 minutes ago
How come this stock plummeted from $125 down to 40 cents . Was it bankrupt ? Makes no sense to me.
GWAV
gitreal gitreal 6 minutes ago
Too long, has to fit in the box. How bout "I'ma Scumbag..Nuf Said". That's more or less what you were saying.
BMXI
Lifetime Lifetime 6 minutes ago
Has BIEL applied for this patent?
BIEL
janice shell janice shell 7 minutes ago
In fairness they are not equipped or staffed for orthopedic rehab so you were in a better place than the hospital.

Definitely. It was quite pleasant. Hospitals are not.
zab zab 8 minutes ago
https://www.msn.com/en-us/news/politics/house-republicans-propose-up-to-3-trillion-in-spending-cuts-to-fund-tax-cuts-package/ar-AA1xQFJ3?ocid=BingNewsSerp

Nothing like trump giving massive tax cuts to the rich on the backs of hard-working Americans.
MartinLutherKing MartinLutherKing 10 minutes ago
Live the stargate TTX CRISPR dream with Trump brothers🚀🚀🚀🚀🚀🚀
RNAZ
omda omda 10 minutes ago
Hey to all, what's up with this stock. why don't the price move. With all the new tariffs and oil prices this company should be the best pick for investment. Any feedback/thoughts on this?
OOAG
Myth Myth 10 minutes ago
Golden Earring - Twilight Zone Live

https://www.youtube.com/watch?v=5-4w_YVI2v8
Sunnybank Sunnybank 11 minutes ago
SHORT view IMO. MODS DELETION >>> BAN!!!
SHIBUSD
zab zab 12 minutes ago
https://www.msn.com/en-us/money/other/trump-s-plan-to-crush-irish-economic-miracle/ar-AA1xPRRH?ocid=msedgntp&pc=U531&cvid=b7b52abede6640c8b23f98f5f67d4e11&ei=31

Trump, the master of his own failures.
maronti1 maronti1 13 minutes ago
Eager to see Mr Williams Team!!
VGTL
cojoboy cojoboy 13 minutes ago
How many x100's of times are you going make the same post..to no avail.???🤔🤔🤔
RDAR
janice shell janice shell 13 minutes ago
And I'm sure that's what it's like for the people who live there; a good place to be. My father spent his last few years in one. After he died, they let me live in his apartment for two or three months. It was fine. You could eat in the dining room, or you could cook your own meal or go out and buy
2cents4one 2cents4one 13 minutes ago
an interesting read on twitter about ELAB
https://stocktwits.com/GatorMcKlusky/message/601468950
ELAB
nagoya1 nagoya1 14 minutes ago
Start off by stating that it’s not his company, it’s held by shareholders with over 1.15B shares. There’s a big azz difference. It’s not a private owned company….
He’s the COO, he’s allowed to buy…as long as he discloses and there must be other internal mechanisms for the purchases not to du
FNMA